73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Combination treatment shows promise in patients with chemotherapy-resistant urothelial cancer

Combination treatment shows promise in patients with chemotherapy-resistant urothelial cancer

byWolters Kluwer HealthGraphical abstract. Credit:Journal of Urology(2022). DOI: 10.1097/JU.0000000000002969A combination of two types of cancer-fighting treatments—the immunotherapy

Combination treatment shows promise in patients with chemotherapy-resistant urothelial cancer

byWolters Kluwer HealthGraphical abstract. Credit:Journal of Urology(2022). DOI: 10.1097/JU.0000000000002969A combination of two types of cancer-fighting treatments—the immunotherapy
Smartphone app monitors cancer patients recovery

Smartphone app monitors cancer patients recovery

by University of Pittsburgh Schools of the Health SciencesCredit: CC0 Public DomainCancer patients receiving chemotherapy can be remotely monitored using their smartphone sensors and an algorithm

Smartphone app monitors cancer patients recovery

by University of Pittsburgh Schools of the Health SciencesCredit: CC0 Public DomainCancer patients receiving chemotherapy can be remotely monitored using their smartphone sensors and an algorithm
New compound advances into Phase 1 trial for pancreatic cancer

New compound advances into Phase 1 trial for pancreatic cancer

by Sanford Burnham Prebys Medical Discovery InstituteErkki Ruoslahti, M.D., Ph.D., distinguished professor at SBP and founder, president and CEO of DrugCendR. Credit: John GestaldoA compound disc

New compound advances into Phase 1 trial for pancreatic cancer

by Sanford Burnham Prebys Medical Discovery InstituteErkki Ruoslahti, M.D., Ph.D., distinguished professor at SBP and founder, president and CEO of DrugCendR. Credit: John GestaldoA compound disc
Incidence of early-stage breast CA, CRC up with ACA adoption

Incidence of early-stage breast CA, CRC up with ACA adoption

(HealthDay)—After adoption of the Affordable Care Act (ACA), there was an increase in the incidence of early-stage breast and colorectal cancer, according to a research letter published online Nov. 2

Incidence of early-stage breast CA, CRC up with ACA adoption

(HealthDay)—After adoption of the Affordable Care Act (ACA), there was an increase in the incidence of early-stage breast and colorectal cancer, according to a research letter published online Nov. 2
Possible new cancer treatment target discovered

Possible new cancer treatment target discovered

byUniversity of GothenburgChandrasekhar Kanduri and Meena Kanduri, Institute of Biomedicine, Sahlgrenska Academy at the University of Gothenburg. Credit: Elin LindströmResearchers at the Univers

Possible new cancer treatment target discovered

byUniversity of GothenburgChandrasekhar Kanduri and Meena Kanduri, Institute of Biomedicine, Sahlgrenska Academy at the University of Gothenburg. Credit: Elin LindströmResearchers at the Univers
Shot could remove side effects from late-stage head and neck cancer therapy

Shot could remove side effects from late-stage head and neck cancer therapy

by Kayla Wiles,Purdue UniversityCredit: CC0 Public DomainFor advanced stages of head and neck cancer, one of the best treatments is so aggressive that it could bring tooth decay, speech loss, co

Shot could remove side effects from late-stage head and neck cancer therapy

by Kayla Wiles,Purdue UniversityCredit: CC0 Public DomainFor advanced stages of head and neck cancer, one of the best treatments is so aggressive that it could bring tooth decay, speech loss, co
New tools to boost the delivery of drugs to cancer tumours

New tools to boost the delivery of drugs to cancer tumours

by CORDISCredit: Prof Dr Twan LanmersThe treatment of cancer tumours is made complex by their microenvironment and the abnormalities of the blood vessels sustaining them. The EU-funded NeoNaNo pr

New tools to boost the delivery of drugs to cancer tumours

by CORDISCredit: Prof Dr Twan LanmersThe treatment of cancer tumours is made complex by their microenvironment and the abnormalities of the blood vessels sustaining them. The EU-funded NeoNaNo pr
Team identifies protein key to cancer cells ability to spread

Team identifies protein key to cancer cells ability to spread

by University of GuelphProfessor Jim Uniacke in his specialized lab. Credit: Rob O'FlanaganUniversity of Guelph scientists have made a discovery that could reduce the spread of cancer by hind

Team identifies protein key to cancer cells ability to spread

by University of GuelphProfessor Jim Uniacke in his specialized lab. Credit: Rob O'FlanaganUniversity of Guelph scientists have made a discovery that could reduce the spread of cancer by hind
Heart drug could significantly increase survival rates for children with an aggressive form of brain tumour

Heart drug could significantly increase survival rates for children with an aggressive form of brain tumour

by University of NottinghamCredit: CC0 Public DomainResearchers at the University of Nottingham have discovered that repurposing a heart drug could significantly increase the survival rate for ch

Heart drug could significantly increase survival rates for children with an aggressive form of brain tumour

by University of NottinghamCredit: CC0 Public DomainResearchers at the University of Nottingham have discovered that repurposing a heart drug could significantly increase the survival rate for ch
New anti-cancer 'degrader' targets protein essential to infant leukemia

New anti-cancer 'degrader' targets protein essential to infant leukemia

byVan Andel Research InstituteDiscovery of a first-in-class, highly potent VHL-recruiting ENL PROTAC degrader, MS41. Credit:Science Advances(2024). DOI: 10.1126/sciadv.ado1432Scienti

New anti-cancer 'degrader' targets protein essential to infant leukemia

byVan Andel Research InstituteDiscovery of a first-in-class, highly potent VHL-recruiting ENL PROTAC degrader, MS41. Credit:Science Advances(2024). DOI: 10.1126/sciadv.ado1432Scienti
Scientists develop a new type of anti-cancer agent

Scientists develop a new type of anti-cancer agent

JANUARY 31, 2024by Center for Research in Biological Chemistry and Molecular Materials (CiQUS)Cancer stem cells, marked in red, disappear in the presence of the reference compound (Ru1). Credit: Cente

Scientists develop a new type of anti-cancer agent

JANUARY 31, 2024by Center for Research in Biological Chemistry and Molecular Materials (CiQUS)Cancer stem cells, marked in red, disappear in the presence of the reference compound (Ru1). Credit: Cente
Cilta-cel found highly effective in first real-world study of patients with relapsed or refractory multiple myeloma

Cilta-cel found highly effective in first real-world study of patients with relapsed or refractory multiple myeloma

byAmerican Society of HematologyCredit: Pixabay/CC0 Public DomainIn the first study to report real-world outcomes from ciltacabtagene autoleucel (cilta-cel), a chimeric antigen receptor (CAR)-T

Cilta-cel found highly effective in first real-world study of patients with relapsed or refractory multiple myeloma

byAmerican Society of HematologyCredit: Pixabay/CC0 Public DomainIn the first study to report real-world outcomes from ciltacabtagene autoleucel (cilta-cel), a chimeric antigen receptor (CAR)-T